Patent details

EP3703818 Title: IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA

Basic Information

Publication number:
EP3703818
PCT Application Number:
US2018058039
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187996558
PCT Publication Number:
WO2019089473
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA
French Title of Invention:
ANTAGONISTE D'IL-4R POUR SON UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DE L'ASTHME
German Title of Invention:
IL-4R-ANTAGONISTEN ZUR VERWENDUNG ZUR BEHANDLUNG ODER VERHINDERUNG VON ASTHMA
SPC Number:

Dates

Filing date:
29/10/2018
Grant date:
01/11/2023
EP Publication Date:
09/09/2020
PCT Publication Date:
09/05/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/11/2023
EP B1 Publication Date:
01/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/10/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2023
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Name:
Sanofi Biotechnology
Address:
82 Avenue Raspail, 94250 Gentilly, France (FR)

Inventor

1

Name:
GRAHAM, Neil
Address:
United States (US)

2

Name:
PIROZZI, Gianluca
Address:
United States (US)

3

Name:
AMIN, Nikhil
Address:
United States (US)

4

Name:
TEPER, Ariel
Address:
United States (US)

Priority

1

Priority Number:
201762579120 P
Priority Date:
30/10/2017
Priority Country:
United States (US)

2

Priority Number:
201862710381 P
Priority Date:
16/02/2018
Priority Country:
United States (US)

3

Priority Number:
201862647368 P
Priority Date:
23/03/2018
Priority Country:
United States (US)

4

Priority Number:
18305566
Priority Date:
04/05/2018
Priority Country:
European Patent Office (EPO) (EP)

5

Priority Number:
201862742736 P
Priority Date:
08/10/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61P 11/06; A61K 39/395;

Publication

European Patent Bulletin

1

Issue number:
202344
Publication date:
01/11/2023
Description:
Grant (B1)

2

Issue number:
202349
Publication date:
06/12/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages